GovChime
Notice ID: 06ad1288e758423b8eba34e025cacc09Combined Synopsis/SolicitationArchived

Obtain Clinical Cohort of Patients with Associated Clinical Outcomes, Radiologic Images, and Associated De-Identified Radiology Reports

Archived on September 26, 2026. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
9:00 AM EDT
Posted
September 17, 2026
Notice type
Combined Synopsis/Solicitation
NAICS
611310: Colleges, Universities, and Professional Schools
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH OLAO
Place of performance
Bethesda, Maryland, 20892
Last updated
Oct 28, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
75N98026Q01240
Notice ID
06ad1288e758423b8eba34e025cacc09

Description

The National Institutes of Health (NIH) intends to award a Firm-Fixed-Price Purchase Order to Thomas Jefferson University to Obtain Clinical Cohort of Patients with Associated Clinical Outcomes, Radiologic Images, and Associated De-Identified Radiology Reports.
In accordance with FAR 6.302-1, Only One Responsible Source and No Other Services Will Satisfy Agency Requirements, The requested clinical cohorts, radiographic imaging datasets, clinical outcomes data, and de-identified radiology reports are required to support artificial intelligence-based research focused on evaluating liver cancer risk in patients with cirrhosis and indeterminate liver lesions. The research requires datasets that combine specific patient populations with associated imaging studies and clinical outcomes information to enable the development, validation, and evaluation of predictive models.
Alternative datasets that do not include the required patient populations, imaging data, clinical outcomes information, and associated radiology reports would not provide the information necessary to support the approved research objectives. The absence of any of these data elements would limit the ability to correlate imaging findings with clinical outcomes and would reduce the scientific validity and reliability of the resulting analyses.
Therefore, only datasets containing the required clinical cohorts and associated imaging and outcomes data will satisfy the Government's minimum needs and support the approved research objectives.
The objectives of the maintenance agreement are as follows:
The objective of this requirement is to acquire clinical patient cohorts, associated imaging data, clinical outcomes data, and de-identified radiology reports to support the development and evaluation of A.I. models for liver disease and liver cancer research conducted by the Liver Diseases Branch.
A determination by the Government to compete this proposed acquisition based upon responses received to this notice is solely within the discretion of the Government.
The proposed contractor maintains an existing cohort of patients with cirrhosis and associated radiographic images collected at six-month intervals, as well as an existing cohort of patients with cirrhosis and indeterminate liver lesions, including associated clinical outcomes data and radiographic images. These clinical cohorts and associated datasets represent a unique research resource available through the proposed contractor.
The combination of longitudinal imaging data, clinical outcomes data, and radiographic images associated with these patient populations is available only through the proposed
contractor. As a result, only the proposed contractor can provide the requested deliverables necessary to support the research project.
It is anticipated that an award will be issued approximately five (5) calendar days after the closing date of this notice, unless the Government determines that another vendor has the capability to meet this requirement.
Please submit responses electronically to davisroshonna@mail.nih.gov no later than 9:00 a.m. EDT on September 25, 2026.
Please reference Notice No. 75N98026Q01240 in the subject line of the response.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Documents

No documents available.

Lifecycle

  1. 1
    Version 1Combined Synopsis/SolicitationArchived

    Obtain Clinical Cohort of Patients with Associated Clinical Outcomes, Radiologic Images, and Associated De-Identified Radiology Reports

    Notice 54d95875ec054bc3aa1aaba9898389ff on SAM.gov

  2. 3
    Version 3Combined Synopsis/SolicitationArchivedCurrent

    Obtain Clinical Cohort of Patients with Associated Clinical Outcomes, Radiologic Images, and Associated De-Identified Radiology Reports

    Notice 06ad1288e758423b8eba34e025cacc09 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98026Q01209/PCA-NIA-08501. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition (including brand-name, if applicable). This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii). The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm fix-price award on a non-competitive basis to Epigenetic Clock Development Foundation 1124 W. Carson Street, MRL Bldg., 3rd Floor Torrance, CA 90502 US to provide obtain DNA methylation profiling and epigenetic age analysis for 320 previously extracted murine DNA samples using the Mammal320K methylation array and established Horvath epigenetic clock methodologies.
40%
Combined Synopsis09/23/2026
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98026Q01212/PCA-NIA-08124. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition (including brand-name, if applicable). This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii). The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm fix-price award on a non-competitive basis to Metabolon Inc. 617 Davis Drive, Suite 100, Morrisville, NC 27560 to assay global metabolomics data and short chain fatty acids (SCFA) via the Metabolon platform from 369 blood samples in the BLSA. These metabolomics data will be used to identify metabolomic signatures of anthropometric aging quantified via a 3D body scanner.
40%
Combined Synopsis09/23/2026
Centers for Disease Control (CDC) is issuing this synopsis as a means of conducting market research to identify parties having an interest in and the resources to support this requirement for a California-based integrated health care system to serve as an electronic health record site in CDC’s VISION 2.0 respiratory pathogen surveillance network, providing integrated, longitudinal medical, laboratory, pharmacy, vaccination, claims, and outcomes data to support influenza surveillance, vaccine-effectiveness studies, and related respiratory pathogen research across emergency/urgent care, inpatient, and intensive care unit (ICU) settings. The result of this market research will contribute to determining the method of acquisition. The applicable North American Industry Classification System (NAICS) code assigned to this acquisition is 541380- Testing Laboratories and Services.
35%
Market Research12/04/2026
Whole Genome DNA Methylation and Genotyping for SLE patients, Third Phase
69%
AwardedOpen
Mayo Clinic Laboratory Testing Services
69%
AwardedOpen

Additional Details

Solicitation Number

75N98026Q01240

Archive Date

Sep 26, 2026

Office Address

BETHESDA, MD, 20892